FOLLOW US

  • facebook
  • twitter
Tue

March 10, 2026

America October 4, 2024

SEC Fines Cassava $40M for Misleading Alzheimer’s Drug Trial Data

Neuroscience-focused biopharmaceutical company Cassava Sciences Inc. and two former executives have agreed to pay over $40 million to resolve U.S.…

By USA Herald

BorrowMoney SEC Suit

America June 27, 2024

BorrowMoney SEC Suit Over Allegedly Fictitious Revenue

The U.S. Securities and Exchange Commission has filed a lawsuit against BorrowMoney.com Inc. and its CEO, Aldo Piscitello, accusing them…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter